SIBN vs LUNG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

SIBN

49.1
AI Score
VS
LUNG Wins

LUNG

49.6
AI Score

Investment Advisor Scores

SIBN

49score
Recommendation
HOLD

LUNG

50score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SIBN LUNG Winner
Revenue 108.60M 43.34M SIBN
Net Income -8.42M -23.73M SIBN
Gross Margin 79.6% 78.0% SIBN
Net Margin -7.8% -54.8% SIBN
Operating Income -9.90M -22.01M SIBN
ROE -4.6% -60.6% SIBN
ROA -3.4% -20.7% SIBN
Total Assets 248.76M 114.73M SIBN
Cash 33.13M 55.84M LUNG
Debt/Equity 0.20 0.96 SIBN
Current Ratio 9.15 4.32 SIBN
Free Cash Flow -4.21M -15.32M SIBN

Relative Price Performance (Last 90 Days)

SIBN 1M: -3.3% · 3M: +21.4% LUNG 1M: -19.2% · 3M: +30.3%

Current Technical Phase

SIBN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $18.38

LUNG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 38

RSI (14): 37.6 · Price: $1.85

Fundamentals Snapshot

Metric SIBN LUNG
Market Cap
Forward P/E -55.6 -2.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.8% 0.8%
Operating Margin -0.1% -0.4%
EPS -0.33 -1.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LUNG is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.